CHARLES J. HOMCY - Director at Maze Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
MAZE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by CHARLES J. HOMCY since 22 Jan 2025

Holdings reported by CHARLES J. HOMCY for Maze Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 31,113 $1,033,573 $33.22 19 Nov 2025 Direct
Common Stock 7,422 $246,558 $33.22 19 Nov 2025 By Trust
Stock Option (Right to Buy) 18,000 22 Sep 2025 Direct Common Stock
Series D-1 Preferred Stock 7,422 26 Nov 2024 By Trust Common Stock
Series B Preferred Stock 0 03 Feb 2025 Direct Common Stock
Series C Preferred Stock 0 03 Feb 2025 Direct Common Stock
8% Convertible Note due 2026 $0 26 Nov 2024 By Trust Series D-1 Preferred Stock

Transactions reported by CHARLES J. HOMCY for Maze Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.